Meeder Asset Management Inc Vbi Vaccines Inc Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$2.15 - $3.5 $240 - $392	-112 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.73 - $1.91 $21 - $55	29 Added 34.94%	112 $0
Q4 2019 Feb 13, 2020	BUY	$0.48 - $1.38 $39 - $114	83 New	83 $0
Q2 2019 Aug 05, 2019	SELL	$0.65 - $2.12 $2,956 - $9,641	-4,548 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$1.22 - $2.41 $1,549 - $3,060	-1,270 Reduced 21.83%	4,548 $7,000
Q3 2018 Nov 02, 2018	BUY	$1.75 - $2.93 $9,191 - $15,388	5,252 Added 927.92%	5,818 $0
Q1 2018 May 03, 2018	BUY	$3.5 - $4.47 $437 - $558	125 Added 28.34%	566 $2,000
Q4 2017 Feb 02, 2018	BUY	$3.29 - $5.03 $1,450 - $2,218	441	441 $1,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.